Stay updated on M7824 for Recurrent Respiratory Papillomatosis Clinical Trial
Sign up to get notified when there's something new on the M7824 for Recurrent Respiratory Papillomatosis Clinical Trial page.

Latest updates to the M7824 for Recurrent Respiratory Papillomatosis Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows an updated revision banner: Revision: v3.4.2 replacing Revision: v3.4.1. No study data, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous v3.4.0. This is a frontend update with no changes to study details or required actions.SummaryDifference0.1%

- Check36 days agoChange DetectedAdditions include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; deletions include Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4. The v3.3.3 entry was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedLocations section updated to include Maryland (Maryland location added) and the Maryland Locations entry removed; page revision updated to v3.3.3.SummaryDifference0.2%

- Check93 days agoChange DetectedThe update is a minor revision from v3.3.1 to v3.3.2 and does not affect the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to M7824 for Recurrent Respiratory Papillomatosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 for Recurrent Respiratory Papillomatosis Clinical Trial page.